M16 family

M16 family
Name	M16 family
Caption	M16 protease fold schematic
Pfam	PF05116
Prosite	PS51233
Merops	M16
Type	Metalloprotease family

M16 family

The M16 family comprises a group of zinc-dependent proteases characterized by a conserved metallopeptidase fold and catalytic motif, found across bacteria, archaea, and eukaryotes. Members include mitochondrial and organellar peptidases involved in polypeptide processing and quality control, with representatives implicated in proteostasis, organelle biogenesis, and pathogen virulence. Notable model organisms and repositories that have contributed sequence and structural data include Escherichia coli, Saccharomyces cerevisiae, Homo sapiens, Arabidopsis thaliana, Mycobacterium tuberculosis, Bacillus subtilis, Plasmodium falciparum, Trypanosoma brucei, Drosophila melanogaster, and entries in databases such as Protein Data Bank, UniProt, and Pfam.

Overview

The family was defined by early biochemical and structural studies of peptidases such as the mitochondrial processing peptidase characterized in HeLa cell mitochondria and the insulin-degrading enzyme studied in New England Biolabs-era research. Comparative genomics surveys across projects like ENCODE, 1000 Genomes Project, and comparative efforts led by groups at institutions including Max Planck Society, National Institutes of Health, and European Molecular Biology Laboratory expanded the catalog of M16 homologs. Structural biology centers at European Synchrotron Radiation Facility and APS provided crystallographic models that revealed the characteristic clamshell architecture. Functional annotation pipelines from Gene Ontology and motif resources such as PROSITE helped define conserved catalytic residues.

Members and nomenclature

Members are named variably as mitochondrial processing peptidase (MPP), presequence protease (PreP), insulin-degrading enzyme (IDE), pitrilysin, and several bacterial lethality-associated peptidases. Representative names include: MPP α and β subunits in Homo sapiens mitochondria, Saccharomyces cerevisiae homologs Mas1 and Mas2, human IDE, Arabidopsis thaliana AtPreP, bacterial pitrilysin from Escherichia coli, Mycobacterium tuberculosis proteases, and parasite orthologs in Plasmodium falciparum and Trypanosoma brucei. Nomenclature conventions often reflect the source organelle (mitochondrial, chloroplast), enzymatic activity (endopeptidase, processing peptidase), or historical discovery in labs at institutions such as Harvard University, Stanford University, and University of Cambridge.

Structure and mechanism

Crystal and cryo-EM structures solved at facilities like Diamond Light Source and National Center for CryoEM reveal a two-domain or multi-domain "clamshell" topology that encloses substrates. The active site coordinates a catalytic zinc ion via conserved residues within the HXXEH motif, a hallmark used to classify members in databases like MEROPS. Mechanistic proposals based on biochemical assays from labs at Massachusetts Institute of Technology and kinetic analyses published in journals associated with societies such as the American Chemical Society describe a metal-activated water molecule that performs nucleophilic attack, substrate-induced domain closure, and product release. Structural comparisons with metallopeptidases characterized at Cold Spring Harbor Laboratory demonstrate substrate-binding pockets that determine specificity for targeting presequences, signaling peptides, or aggregated peptides.

Biological functions and regulation

M16 proteases execute intramitochondrial precursor processing, degrade misfolded or aggregation-prone peptides, and modulate signaling peptide levels in pathways studied in models like Drosophila melanogaster development and Arabidopsis thaliana chloroplast biology. Regulation occurs via gene expression controlled by transcription factors cataloged at ENCODE datasets, post-translational modifications observed in mass spectrometry datasets from ProteomeXchange, and assembly dynamics influenced by chaperones such as Hsp60 and proteostasis factors studied at Broad Institute. Cellular stressors investigated in contexts like Parkinson's disease and Alzheimer's disease models modulate activity and localization through proteolytic processing, redox state, and cofactor availability.

Evolution and phylogeny

Phylogenetic analyses using sequence repositories like GenBank and tools developed at European Bioinformatics Institute place M16 family members into distinct clades corresponding to mitochondrial, bacterial, and eukaryotic lineages. Horizontal gene transfer events inferred from comparative genomics in organisms such as Mycobacterium tuberculosis, Pseudomonas aeruginosa, and symbionts in Hawaiian bobtail squid illuminate evolutionary trajectories. Studies combining molecular clock estimates from groups at University of Oxford and domain architecture comparisons reported by researchers at Sanger Institute suggest ancient origin predating the mitochondrial endosymbiosis hypothesized by proponents of endosymbiotic theory including researchers affiliated with University of California, Berkeley.

Clinical significance and disease associations

Mutations, dysregulation, or aggregation of M16 family members are associated with human conditions examined in clinical centers like Mayo Clinic, Johns Hopkins Hospital, and Massachusetts General Hospital. IDE variants have been linked to altered peptide catabolism implicated in Type 2 diabetes mellitus and amyloid pathology relevant to Alzheimer's disease cohorts studied in consortia such as Alzheimer's Disease Neuroimaging Initiative. Defects in mitochondrial processing peptidases correlate with mitochondrial encephalopathies reported in case series from Children's Hospital Boston and metabolic disorder registries. Pathogen M16 proteases are explored as virulence factors and drug targets in tuberculosis research at Wellcome Trust-funded centers and antimalarial efforts at Medicines for Malaria Venture.

Experimental methods and research directions

Current methods include X-ray crystallography and cryo-electron microscopy at facilities like European Synchrotron Radiation Facility, activity assays developed in biochemical labs at Cold Spring Harbor Laboratory, high-throughput screening pipelines at Drug Discovery Unit sites, and genetics using CRISPR platforms pioneered at Broad Institute. Proteomics and interactomics leveraging MassIVE datasets, and in vivo models in Mus musculus and Drosophila melanogaster are informing substrate repertoires and regulation. Emerging directions focus on small-molecule modulators, structure-guided inhibitor design coordinated with medicinal chemistry groups at Novartis and Pfizer, and systems-biology integration across consortia such as Human Cell Atlas to map physiological roles and therapeutic potential.

Category:Protease families